Search research articles
Contact Us
Filters
Showing results (31-40 of 101) with videos related to
Page
of 11
Sort By:
Journal of Clinical Pharmacology
|
August 1, 1987
Hemodynamic effects of esmolol, an ultrashort-acting beta blocker
J Askenazi, P E MacCosbe, J Hoff, et al.
Insect Molecular Biology
|
April 23, 2002
Germ line transformation of the yellow fever mosquito, Aedes aegypti, mediated by transpositional insertion of a piggyBac vector
N F Lobo, A Hua-Van, X Li, et al.
Blood Pressure
|
January 26, 2016
Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial
Tonje A Aksnes, Sverre E Kjeldsen, Morten Rostrup, et al.
Blood Pressure
|
January 8, 2019
Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial
Maria H Mehlum, Knut Liestøl, Torgeir B Wyller, et al.
Genome Research
|
February 2, 1999
Comparative sequence of human and mouse BAC clones from the mnd2 region of chromosome 2p13
W Jang, A Hua, S V Spilson, et al.
Journal of Human Hypertension
|
May 30, 2008
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial
T A Aksnes, S E Kjeldsen, M Rostrup, et al.
Molecular Plant-Microbe Interactions : MPMI
|
March 30, 2001
Transposon impala, a novel tool for gene tagging in the rice blast fungus Magnaporthe grisea
F Villalba, M H Lebrun, A Hua-Van, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 8, 2007
Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population
Tonje A Aksnes, Sverre E Kjeldsen, Morten Rostrup, et al.
Genomics
|
March 8, 2000
Comparative sequence analysis of 634 kb of the mouse chromosome 16 region of conserved synteny with the human velocardiofacial syndrome region on chromosome 22q11.2
J Lund, F Chen, A Hua, et al.
Journal of Hypertension
|
February 28, 2008
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial
Roland E Schmieder, Sverre E Kjeldsen, Stevo Julius, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 101) with videos related to
Sort By:
Page
of 11
Journal of Clinical Pharmacology
|
August 1, 1987
Hemodynamic effects of esmolol, an ultrashort-acting beta blocker
J Askenazi, P E MacCosbe, J Hoff, et al.
Insect Molecular Biology
|
April 23, 2002
Germ line transformation of the yellow fever mosquito, Aedes aegypti, mediated by transpositional insertion of a piggyBac vector
N F Lobo, A Hua-Van, X Li, et al.
Blood Pressure
|
January 26, 2016
Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial
Tonje A Aksnes, Sverre E Kjeldsen, Morten Rostrup, et al.
Blood Pressure
|
January 8, 2019
Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial
Maria H Mehlum, Knut Liestøl, Torgeir B Wyller, et al.
Genome Research
|
February 2, 1999
Comparative sequence of human and mouse BAC clones from the mnd2 region of chromosome 2p13
W Jang, A Hua, S V Spilson, et al.
Journal of Human Hypertension
|
May 30, 2008
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial
T A Aksnes, S E Kjeldsen, M Rostrup, et al.
Molecular Plant-Microbe Interactions : MPMI
|
March 30, 2001
Transposon impala, a novel tool for gene tagging in the rice blast fungus Magnaporthe grisea
F Villalba, M H Lebrun, A Hua-Van, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 8, 2007
Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population
Tonje A Aksnes, Sverre E Kjeldsen, Morten Rostrup, et al.
Genomics
|
March 8, 2000
Comparative sequence analysis of 634 kb of the mouse chromosome 16 region of conserved synteny with the human velocardiofacial syndrome region on chromosome 22q11.2
J Lund, F Chen, A Hua, et al.
Journal of Hypertension
|
February 28, 2008
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial
Roland E Schmieder, Sverre E Kjeldsen, Stevo Julius, et al.
Page
of 11